|本期目录/Table of Contents|

[1]孙建军,马建芳,王晨光,等.综合介入治疗原发性肝癌长期存活34例[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):411.
　SUN Jian-jun,MA Jian-fang,WANG Chen-guang,et al.Clinical analysis of 34 cases of primary liver cancer survived for more than 5 years after comprehensive interventional therapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(06):411.
点击复制

综合介入治疗原发性肝癌长期存活34例()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第10卷
期数:
2008年06期
页码:
411
栏目:
出版日期:
2008-11-20

文章信息/Info

Title:
Clinical analysis of 34 cases of primary liver cancer survived for more than 5 years after comprehensive interventional therapy
文章编号:
1672-271X(2008)06-0411-03
作者:
孙建军; 马建芳; 王晨光; 黄祖泉
解放军476临床部放射科，福建福州 350002
Author(s):
SUN Jian-jun; MA Jian-fang; WANG Chen-guang; HUANG Zu-quan
Department of Radiology,the 476th Clinical Branch of PLA,Fuzhou 350002,Fujian,China
关键词:
原发性肝癌; 综合介入治疗; 远期疗效
Keywords:
Primary liver cancer;  Comprehensive interventional therapy;  Long-term effect evaluation
分类号:
R735.7
DOI:
-
文献标志码:
A
摘要:
目的 探讨综合介入治疗原发性肝癌对提高患者生存率的临床价值。方法 回顾性分析34例经综合介入治疗后存活5年以上的原发性肝癌患者的临床治疗和随访资料。结果 介入治疗前肿瘤Ⅰ期20例，Ⅱ期14例；单发病灶23例，多发灶10例，巨块型1例；肿瘤直径<3 cm、3~5 cm、5~10 cm 和>10 cm者分别为8例、18例、7例和1例。所有患者均采用TXCE联合其他治疗，均存活5年以上，其中1例存活11年。结论 综合介入治疗可显著提高原发性肝癌患者生存率。
Abstract:
Objective To investigate the clinical value of comprehensive interventional therapy in increase of survival rate for patients with primary liver cancer. Methods The clinical data, therapeutic protocols and follow up of patients with primary liver cancer survived more than 5 years after comprehensive interventional therapy were retrospectively analyzed.Results Before TACE, 20 patients were in clinical stage I and 14 cases in stage Ⅱ.The tumor patterns included mononodular type (23 cases), multimodal type (10 cases), and greatest mass (1 cases).The diameter of tumor demonstrated less than 3 cm (8 cases), 3 to 5 cm (18 cases), 5 to 10 cm (7 cases) and more than 10 cm (1 cases). All cases were treated by TACE combined other treatment. All patients survived for more than 5 years, including 1 case 11 years.Conclusion Comprehensive interventional therapy can significantly increase survival rate for patients with primary liver cancer.

参考文献/References:

[1]中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志，2001，9(6):324-326.
[2]王建华.肝癌综合介入治疗的现状[J].中华肝脏病杂志，2005，13(10):721-723.
[3]Level JM, Real MI,Montena X,et al.Arterial embolisation or chemoembolization versus symptomatic treatment in patients with unrese ctable hepatocellular carcinoma;a randomized controlled trial[J].Lancet,2002,359:1734-1739.
[4]周大勇，王建华，钱 晟，等.肝动脉化疗栓塞术对富血供肝转移瘤的疗效分析[J].介入放射学杂志，2007，16(3):165-167.
[5]周泽健，罗鹏飞，邵培坚，等.介入治疗后38例中晚期肝癌患者生存5年以上的因素分析[J].中华放射学杂志，2002，36(9):792-796.
[6]王建华，周康荣.肝癌综合治疗规范化方案(草案)[J].临床放射学杂志，2002，21(7):497-500.
[7]马爱英，沈 杰，王海洁，等.肝动脉化疗栓塞联合经皮微波凝固治疗晚期肝癌[J].介入放射学杂志，2007，16(3):201-203.
[8]冯耀良，赵林波，王学浩，等.中晚期肝癌肝移植术前介入治疗的临床价值[J].介入放射学杂志，2007，16(7):464-467.

相似文献/References:

[1]司 芩,钱晓莉,仝 威,等.实时超声造影对肝硬化背景下占位病变的鉴别诊断[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):121.
　SI Qin,QIAN Xiao-li,TONG Wei,et al.Differential diagnosis of focal hepatic cirrhosis lesions using real-time contrast-enhanced ultrasound[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(06):121.
[2]倪 晶 综述,华海清 审校.索拉非尼联合中药治疗原发性肝癌的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):175.[doi:10.3969/j.issn.1672-271X.2015.02.020]
[3]严海鸥,郝海燕,黄学芳,等.应对方式对原发性肝癌患者情绪和生活质量的影响[J].医学研究与战创伤救治(原医学研究生学报),2017,19(01):83.[doi:10.3969/j.issn.1672-271X.2017.01.023]
[4]蒋伟,李涛综述,季国忠审校.原发性肝癌免疫治疗的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2019,21(6):625.[doi:10.3969/j.issn.1672-271X.2019.06.016]
　JIANG Wei,LI Tao reviewing,JI Guo-zhong checking.The research progress of immunotherapy in hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(06):625.[doi:10.3969/j.issn.1672-271X.2019.06.016]
[5]沈兰超,张梅芹,许敏,等.华蟾素肝动脉推注联合化疗药物热灌注治疗原发性肝癌的临床价值[J].医学研究与战创伤救治(原医学研究生学报),2020,22(3):292.[doi:10.3969/j.issn.1672-271X.2020.03.015]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2013-11-22